329 related articles for article (PubMed ID: 17502344)
1. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ
Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
[TBL] [Abstract][Full Text] [Related]
3. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
[TBL] [Abstract][Full Text] [Related]
4. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
5. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
[TBL] [Abstract][Full Text] [Related]
6. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
7. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
[TBL] [Abstract][Full Text] [Related]
9. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.
Sung FY; Jung CM; Wu CF; Lin CL; Liu CJ; Liaw YF; Tsai KS; Yu MW
Gastroenterology; 2009 Nov; 137(5):1687-97. PubMed ID: 19664630
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
Yuan J; Zhou B; Tanaka Y; Kurbanov F; Orito E; Gong Z; Xu L; Lu J; Jiang X; Lai W; Mizokami M
J Clin Virol; 2007 Jun; 39(2):87-93. PubMed ID: 17451999
[TBL] [Abstract][Full Text] [Related]
12. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus BCP, Precore/core, X gene mutations/genotypes and the risk of hepatocellular carcinoma in India.
Asim M; Malik A; Sarma MP; Polipalli SK; Begum N; Ahmad I; Khan LA; Husain SA; Akhtar N; Husain S; Thayumanavan L; Singla R; Kar P
J Med Virol; 2010 Jul; 82(7):1115-25. PubMed ID: 20513073
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
[TBL] [Abstract][Full Text] [Related]
16. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
17. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
Wu CF; Yu MW; Lin CL; Liu CJ; Shih WL; Tsai KS; Chen CJ
Carcinogenesis; 2008 Jan; 29(1):106-12. PubMed ID: 17999990
[TBL] [Abstract][Full Text] [Related]
18. [Risk features of HBV in human hepatocarcinogenesis: a nested case-controlled study].
Zhang F; Shao YF; Gao JD; Xu Y; Liu GT; Xu LB; Wu ZY; Gao WH; Sun ZT
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1482-4. PubMed ID: 18275715
[TBL] [Abstract][Full Text] [Related]
19. Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.
Khan A; Al Balwi MA; Tanaka Y; Hajeer A; Sanai FM; Al Abdulkarim I; Al Ayyar L; Badri M; Saudi D; Tamimi W; Mizokami M; Al Knawy B
Int J Cancer; 2013 Dec; 133(12):2864-71. PubMed ID: 23740667
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]